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INVITED COMMENTARY
Mark F. Fillinger, MD Lebanon, NH
This is an important article about an endovascular tour de
force: the development and implantation of branched endografts
for complex aortoiliac anatomy. It should be clear that this is not a
procedure for the faint of heart or those lacking state-of-the-art
endovascular interventional skills. Even in the hands of highly
skilled interventionalists who are worldwide leaders in the tech-
nique, fluoroscopy times averaged 60 minutes for the more
straightforward iliac and suprarenal cases and a sobering 117
minutes for the thoracoabdominal cases.
In the high-risk patient cohort for whom the procedure is
desired, this minimally invasive procedure carries significant risk: of
the 29 suprarenal and thoracoabdominal aneurysms, there were
four aneurysm-related deaths and two cases of paraparesis and
paraplegia. Thus, branched-graft endovascular aneurysm repair for
thoracoabdominal aneurysms is not something that can or should
be adopted by the average center in the very near future.
To be sure, this report represents the learning curve of a very
complex procedure performed in a difficult patient population. In
the early 1990s, endovascular repair of typical infrarenal abdominal
aortic aneurysms (AAAs) was challenging also, causing many to
wonder whether it would ever be adopted on a wide scale. Despite
this, clinical pioneers and early adopters worked with manufactur-
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ers to develop techniques and devices that work well, are applicable
to most infrarenal AAAs, and produce one-third the mortality rate
of open repair. Despite ongoing work to improve durability, the
aneurysm-related mortality advantage for endovascular repair of
conventional aneurysms persists out to 2 to 4 years in randomized,
prospective trials.1,2
This report by Greenberg et al is evidence that branched-
endograft technology has a likely development pathway. Initially,
the technology will be applied in the least challenging and least
risky cases: branched endografts for maintaining internal iliac
artery perfusion. In conjunction with simpler, single-vessel fenes-
trated endograft technology, highly experienced endovascular cen-
ters will advance their expertise further in this area by treating
juxtarenal and suprarenal aortic aneurysms. As the methods and
materials technology mature, branched endografts for more com-
plex thoracoabdominal aortic aneurysms will likely expand to a
relatively small number of centers in the context of clinical trials.
Whether it will expand beyond that is anyone’s guess, but recent
history makes it seem unwise to think that branched endograft
technology will remain limited to only a handful of centers.
On the other hand, the recent Endovascular Aneurysm Repair
2 (EVAR 2) trial3 gives one pause to regard how broadly this
technology should be applied, at least in thoracoabdominal aneu-
rysms. Many of these high-risk patients have a relatively short life
expectancy, but need to live long enough to benefit from aneurysm
repair if this new procedure is to be considered. Thus, patient
selection will become even more crucial in this patient cohort,
where anatomic evaluation will obviously be more challenging
than for conventional endografts. At least in the near term, this
highly complex technology needs to be developed under the strict
scrutiny of well-documented clinical trials sponsored by manufac-
turers or centers of expertise.
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